MOORE TIMOTHY L. 4
4 · Allogene Therapeutics, Inc. · Filed Apr 26, 2023
Insider Transaction Report
Form 4
MOORE TIMOTHY L.
Chief Technical Officer
Transactions
- Award
Common Stock
2023-04-24+186,219→ 186,219 total - Award
Stock Option (Right to Buy)
2023-04-24+831,024→ 831,024 totalExercise: $5.37Exp: 2033-04-24→ Common Stock (831,024 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on April 24, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.